VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis
- PMID: 12837578
- DOI: 10.1016/s1050-1738(03)00056-2
VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis
Abstract
Angiogenic cytokines such as vascular endothelial growth factor-A(164/165) (VEGF-A(164/165)) and placenta growth factor (PlGF) are being considered for therapeutic relief of coronary heart disease and other forms of tissue ischemia caused by atherosclerosis. Before proceeding further with clinical testing, it is important to determine what types of new blood vessels these cytokines actually induce and whether they could provide a useful new blood supply to ischemic tissues. In mice, VEGF-A(164/165) induced a transient angiogenic response (mother vessels, glomeruloid bodies, daughter capillaries), and stable arteriovenous malformations, arteriogenesis, and lymphangiogenesis; whereas PlGF only induced the formation of large, stable blood vessels. The large, long-lasting blood vessels induced by VEGF-A(164/165) and PlGF could provide an improved blood supply if positioned proximal to ischemic tissue, but VEGF-A(164/165)'s angiogenic response--which is short lived and accompanied by vascular hyperpermeability, edema, and fibrosis--would seem to offer little therapeutic benefit.
Similar articles
-
Structure and function of placental growth factor.Trends Cardiovasc Med. 2002 Aug;12(6):241-6. doi: 10.1016/s1050-1738(02)00168-8. Trends Cardiovasc Med. 2002. PMID: 12242046 Review.
-
The placenta growth factor in skin angiogenesis.J Dermatol Sci. 2006 Jan;41(1):11-9. doi: 10.1016/j.jdermsci.2005.08.008. Epub 2005 Oct 10. J Dermatol Sci. 2006. PMID: 16216466 Review.
-
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.Nat Med. 2002 Aug;8(8):831-40. doi: 10.1038/nm731. Epub 2002 Jul 1. Nat Med. 2002. PMID: 12091877
-
Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2019-26. doi: 10.1161/01.ATV.0000233336.53574.a1. Epub 2006 Jun 22. Arterioscler Thromb Vasc Biol. 2006. PMID: 16794222
-
VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.Circ Res. 2003 Mar 7;92(4):378-85. doi: 10.1161/01.RES.0000057997.77714.72. Epub 2003 Jan 23. Circ Res. 2003. PMID: 12600898
Cited by
-
Cardioprotective activity of placental growth factor combined with oral supplementation of l-arginine in a rat model of acute myocardial infarction.Drug Des Devel Ther. 2016 Oct 28;10:3483-3492. doi: 10.2147/DDDT.S117683. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27822012 Free PMC article.
-
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.Am J Pathol. 2006 Feb;168(2):608-20. doi: 10.2353/ajpath.2006.050677. Am J Pathol. 2006. PMID: 16436674 Free PMC article.
-
Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.Pharm Res. 2005 Jul;22(7):1110-6. doi: 10.1007/s11095-005-5644-2. Epub 2005 Jul 22. Pharm Res. 2005. PMID: 16028011
-
Low Concentrations of Flavonoid - Rich Fraction of Shallot Extract Induce Delayed - Type Hypersensitivity and TH1 Cytokine IFNγ Expression in BALB/c Mice.Int J Mol Cell Med. 2014 Winter;3(1):16-25. Int J Mol Cell Med. 2014. PMID: 24551817 Free PMC article.
-
Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.Blood. 2009 Sep 3;114(10):2197-206. doi: 10.1182/blood-2009-01-199166. Epub 2009 Jun 8. Blood. 2009. PMID: 19506300 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
